Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | AC21B163BC | — |
patient received an expired dose of Pediarix in 2008; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 3-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number AC21B163BC, expiry date 06-OCT-2008) for prophylaxis. On 28-OCT-2008, the patient received Pediarix. On 28-OCT-2008, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: patient received an expired dose of Pediarix in 2008). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-JUN-2025 A medical assistant reported that the patient received an expired dose of Pediarix in 2008 which led to expired vaccine used. The expiration date was 6th October 2008, and the vaccine was given on 28th October 2008. The medical assistant asked if this dose was considered valid. This case is linked with US2025076597, reported by same reporter for different (twin) patient.; Sender's Comments: US-GSK-US2025076597:Same reporter/Diffrent patient